Refeyn announces USP recognizes mass photometry in new AAV reference standards for gene therapy quality: Oxford, UK Friday, ...

Saptalis Pharma launches fluoxetine oral solution, USP 20 mg/5 mL for treatment of mental health conditions: Hauppauge, New York Friday, June 20, 2025, 16:00 Hrs [IST] Hauppauge-H ...

Centre and states in May as NSQs: Our Bureau, New Delhi Friday, June 20, 2025, 15:45 Hrs [IST] A total of 186 drug samples were declared as Not of S ...

Copenhagen, Denmark Friday, June 20, 2025, 15:00 Hrs [IST] ...

Expanding Innovations receives US FDA 510(k) clearance for its spinal fixation platform N-GAGE Lumbar Plate System: Mountain View, California Friday, June 20, 2025, 13:00 Hrs [IST ...

SynaptixBio announces milestone with selection of candidate drug to treat rare disease H-ABC: Our Bureau, Bengaluru Friday, June 20, 2025, 12:30 Hrs [IST] Oxford-based SynaptixBio ...

Gilead Sciences’ Yeztugo receives nod; the first and only US FDA-approved HIV prevention option offering 6 months of protection: Foster City, California Friday, June 20, 2025, 1 ...

US FDA halts new clinical trials that export Americans’ cells to foreign labs in hostile countries for genetic engineering: Maryland Friday, June 20, 2025, 09:00 Hrs [IST] The U ...

WHO issues first global guideline to improve pregnancy care for women with sickle cell disease: Geneva Friday, June 20, 2025, 11:00 Hrs [IST] The World Health Organization (WHO) r ...

Macquarie University’s new study shows DNA 'glue' could help prevent and treat age related disorders: Our Bureau, Bengaluru Thursday, June 19, 2025, 17:15 Hrs [IST] Macquarie Un ...

Researchers at the Indian Institute of Science (IISc) have developed an artificial metal-based nanozyme that can possibly be used to clamp down on abnormal blood clotting caused by conditions like ...

Nikon Instruments and Astellas collaborate to offer SakuLab-Cambridge resident companies access to advanced imaging capabilities: Melville, New York Thursday, June 19, 2025, 17:00 ...